Emeline Nandrot

Dr. Emeline Nandrot

Sorbonne Université UM80, INSERM U968, CNRS UMR7210, Institut de la Vision
orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2013 in EMBO Molecular Medicine
Verified
Journal Article
Open access
PDF file
FSFlorian Sennlaub
Florian Sennlaub
CAConstance Auvynet
Constance Auvynet
BCBertrand Calippe
Bertrand Calippe
SLSophie Lavalette
Sophie Lavalette
LPLucie Poupel
Lucie Poupel
CCChristophe Combadiere
Christophe Combadiere
Atrophic age‐related macular degeneration (AMD) is associated with the subretinal accumulation of mononuclear phagocytes (MPs). Their role in promoting or inhibiting retinal degeneration is unknown. We here show that atrophic AMD is associated with increased intraocular CCL2 levels and subretinal CCR2 + inflammatory monocyte infiltration in patients. Using age‐ and light‐induced subretinal inflammation and photoreceptor degeneration in Cx3cr1 knockout mice, we show that subretinal Cx3cr1 deficient MPs overexpress CCL2 and that both the genetic deletion of CCL2 or CCR2 and the pharmacological inhibition of CCR2 prevent inflammatory monocyte recruitment, MP accumulation and photoreceptor degeneration in vivo . Our study shows that contrary to CCR2 and CCL2, CX3CR1 is constitutively expressed in the retina where it represses the expression of CCL2 and the recruitment of neurotoxic inflammatory CCR2 + monocytes. CCL2/CCR2 inhibition might represent a powerful tool for controlling inflammation and neurodegeneration in AMD.

20 February 2017 in Stem Cells
Verified
Journal Article
Open access
PDF file
SRSacha Reichman
Sacha Reichman
ASAmélie Slembrouck
Amélie Slembrouck
GGGiuliana Gagliardi
Giuliana Gagliardi
ACAntoine Chaffiol
Antoine Chaffiol
ATAngélique Terray
Angélique Terray
OGOlivier Goureau
Olivier Goureau
Human induced pluripotent stem cells (hiPSCs) are potentially useful in regenerative therapies for retinal disease. For medical applications, therapeutic retinal cells, such as retinal pigmented epithelial (RPE) cells or photoreceptor precursors, must be generated under completely defined conditions. To this purpose, we have developed a two-step xeno-free/feeder-free (XF/FF) culture system to efficiently differentiate hiPSCs into retinal cells. This simple method, relies only on adherent hiPSCs cultured in chemically defined media, bypassing embryoid body formation. In less than 1 month, adherent hiPSCs are able to generate self-forming neuroretinal-like structures containing retinal progenitor cells (RPCs). Floating cultures of isolated structures enabled the differentiation of RPCs into all types of retinal cells in a sequential overlapping order, with the generation of transplantation-compatible CD73+ photoreceptor precursors in less than 100 days. Our XF/FF culture conditions allow the maintenance of both mature cones and rods in retinal organoids until 280 days with specific photoreceptor ultrastructures. Moreover, both hiPSC-derived retinal organoids and dissociated retinal cells can be easily cryopreserved while retaining their phenotypic characteristics and the preservation of CD73+ photoreceptor precursors. Concomitantly to neural retina, this process allows the generation of RPE cells that can be effortlessly amplified, passaged, and frozen while retaining a proper RPE phenotype. These results demonstrate that simple and efficient retinal differentiation of adherent hiPSCs can be accomplished in XF/FF conditions. This new method is amenable to the development of an in vitro GMP-compliant retinal cell manufacturing protocol allowing large-scale production and banking of hiPSC-derived retinal cells and tissues.

17 July 2007 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
ENEmeline Nandrot
Emeline Nandrot
MAMonika Anand
Monika Anand
DADena Almeida
Dena Almeida
KAKamran Atabai
Kamran Atabai
DSDean Sheppard
Dean Sheppard
SFSilvia C. Finnemann
Silvia C. Finnemann
The integrin receptor αvβ5 controls two independent forms of interactions of the retinal pigment epithelium (RPE) with adjacent photoreceptor outer segments that are essential for vision. αvβ5 localizes specifically to apical microvilli of the RPE and contributes to retinal adhesion that maintains RPE contacts with intact outer segments at all times. Additionally, αvβ5 synchronizes diurnal bursts of RPE phagocytosis that clear photoreceptor outer segment fragments (POS) shed in a circadian rhythm. Dependence of retinal phagocytosis and adhesion on αvβ5 receptors suggests that the extracellular matrix ensheathing RPE microvilli contains ligands for this integrin. Here we studied mice lacking expression of functional MFG-E8 to test the contribution of this integrin ligand to αvβ5 functions in the retina. Lack of MFG-E8 only minimally reduced retinal adhesion. In contrast, lack of MFG-E8, like lack of αvβ5 receptor, eliminated αvβ5 downstream signaling involving the engulfment receptor MerTK and peak POS phagocytosis, both of which follow light onset in wild-type retina. MFG-E8-deficient RPE in primary culture retained normal epithelial morphology and levels of apical αvβ5 receptors, but showed impaired binding and engulfment of isolated POS. Soluble or POS-bound recombinant MFG-E8 was sufficient to fully restore phagocytosis by MFG-E8-deficient RPE. Furthermore, MFG-E8 supplementation strongly increased POS binding by wild-type and MerTK-deficient RPE, but did not affect POS binding by RPE lacking αvβ5. Thus, MFG-E8 stimulates rhythmic POS phagocytosis by ligating apical αvβ5 receptors of the RPE. These results identify MFG-E8 as the first extracellular ligand in the retina that is essential for diurnal POS phagocytosis.

1 November 2009 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
IAIsabelle Audo
Isabelle Audo
SKSusanne Kohl
Susanne Kohl
BLBart P. Leroy
Bart P. Leroy
FMFrancis L. Munier
Francis L. Munier
Xavier GuillonneauXavier Guillonneau
Xavier Guillonneau
Christina ZeitzChristina Zeitz
Christina Zeitz

1 December 2000 in Neurobiology of Disease
Verified
Journal Article
Closed access
ENEmeline Nandrot
Emeline Nandrot
EDEric M Dufour
Eric M Dufour
APAlexandra C Provost
Alexandra C Provost
MPMarie O Péquignot
Marie O Péquignot
SBSébastien Bonnel
Sébastien Bonnel
MAMarc M Abitbol
Marc M Abitbol

23 March 2010 in Human Mutation
Verified
Journal Article
Open access
PDF file
IAIsabelle Audo
Isabelle Audo
JSJosé-Alain Sahel
José-Alain Sahel
SMSaddek Mohand-Saïd
Saddek Mohand-Saïd
MLMarie-Elise Lancelot
Marie-Elise Lancelot
AAAline Antonio
Aline Antonio
Christina ZeitzChristina Zeitz
Christina Zeitz
Autosomal‐recessive retinitis pigmentosa (arRP) was recently associated with mutations in a novel gene EYS, spanning over 2 Mb, making it the largest known gene expressed in the human eye. The purpose of this study was to establish the prevalence and nature of EYS mutations in a clinically well‐characterized cohort of 239 sporadic and arRP French cases. Direct sequencing of EYS was performed in 186 subjects for whom known mutations had previously been excluded by applying microarray technology. We mostly identified novel mutations in EYS in a total of 29 patients: Fifteen of the mutations were predicted to create premature stop codons and two represent exonic deletions. In addition, twenty missense, silent or splice‐site mutations were detected. Patients revealed homozygous or compound heterozygous mutations and in some cases, only a single mutation. Most patients showed classical signs of RP with relatively preserved central vision and visual field until late in the course of the disorder. One patient showed predominance of the disease in the inferior part of the retina suggesting potential phenotypic variability. With a prevalence of 12% or more we provide evidence that EYS is a major gene for RP in France and probably elsewhere.